Delivery Order SPE2DE24D0013-SPE2D625F3VPY
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $31,775.10 by the Defense Department's Medical Supply Chain organization on April 24, 2025. The contract, designated XPRSMVP-10, has an ultimate completion date of May 1, 2025 and carries no set-aside designation. The work will be performed at Cepheid's Sunnyvale facility. This delivery order falls under one of Cepheid's larger Indefinite Delivery...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,514.00 by the Medical Supply Chain, a defense-focused federal agency. The contract, issued on June 12, 2025, with an ultimate completion date of June 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The work will be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $1,854.00 by the Medical Supply Chain (a Defense agency) on May 21, 2025, with an ultimate completion date of May 29, 2025. The contract, issued without set-aside designation under contract number GXGBSLBXC-10, is to be performed in Sunnyvale, California. This delivery order represents a discrete procurement action under one of Cepheid's existing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $2,208 firm fixed-price delivery order (Contract No. XPRSTREPA-10) by the Medical Supply Chain, a Defense agency component, with a completion deadline of October 3, 2025. This delivery order was issued without a set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award falls under Cepheid's existing federal contracting relationship with defense...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $10,914 on September 22, 2025, by the Defense Logistics Agency's Medical Supply Chain division under the Defense Department. The firm fixed-price delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by October 6, 2025, and will be performed at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents procurement...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3VPYDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,951.40 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, issued on September 18, 2025, carries no set-aside designation and represents work to be performed at Cepheid's headquarters location in Sunnyvale, California. The delivery order is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which provide the company with ongoing procurement vehicles for molecular diagnostic testing systems, reagents, and assays. Cepheid specializes in providing advanced diagnostic systems and test kits for infectious diseases and clinical testing to federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company's core offerings include GeneXpert diagnostic systems and molecular reagents designed to detect conditions such as COVID-19, influenza, respiratory syncytial virus, and other infectious diseases. This delivery order continues Cepheid's established role as a primary supplier of molecular diagnostic solutions within the federal healthcare ecosystem, supporting the ongoing diagnostic and testing needs of defense-affiliated medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/18/25 |